Optic atrophy in prematurity: pathophysiology and clinical features.
Scott DA, Wang MT, Danesh-Meyer HV, Hull S.
Clin Exp Optom. 2024 Apr;107(3):245-254. doi: 10.1080/08164622.2023.2256734. Epub 2023 Oct 22.
Unexplained Bilateral Optic Atrophy for Decades.
Charoenkijkajorn C, Cho J, Lee AG.
J Neuroophthalmol. 2022 Dec 1;42(4):e609. doi: 10.1097/WNO.0000000000001736. Epub 2022 Oct 21.
Pediatric optic atrophy.
Vaphiades MS, Brodsky MC.
Int Ophthalmol Clin. 2012 Summer;52(3):17-28, xiii. doi: 10.1097/IIO.0b013e31825a14ba.
Nonglaucomatous optic atrophy.
Golnik K.
Neurol Clin. 2010 Aug;28(3):631-40. doi: 10.1016/j.ncl.2010.03.005.
[Modern treatment of different forms of optic nerve atrophy].
Drakon AK, Kosova JV, Sheludchenko VM, Korchazhkina NB.
Vestn Oftalmol. 2021;137(5. Vyp. 2):340-345. doi: 10.17116/oftalma2021137052340.
Optic atrophy in children: Current causes and diagnostic approach.
Jones R, Al-Hayouti H, Oladiwura D, Karim R, Sawczenko A, Dahlmann-Noor A.
Eur J Ophthalmol. 2020 Nov;30(6):1499-1505. doi: 10.1177/1120672119899378. Epub 2020 Jan 7.
OPA1 Dominant Optic Atrophy: Pathogenesis and Therapeutic Targets.
Wong DCS, Harvey JP, Jurkute N, Thomasy SM, Moosajee M, Yu-Wai-Man P, Gilhooley MJ.
J Neuroophthalmol. 2023 Dec 1;43(4):464-474. doi: 10.1097/WNO.0000000000001830. Epub 2023 Apr 19.
Dominant Optic Atrophy and Leber's Hereditary Optic Neuropathy: Update on Clinical Features and Current Therapeutic Approaches.
Chun BY, Rizzo JF 3rd.
Semin Pediatr Neurol. 2017 May;24(2):129-134. doi: 10.1016/j.spen.2017.06.001. Epub 2017 Jun 30.
[Pathogenetic basis of optic nerve atrophy in methanol poisoning].
Samoylov AN, Barieva AM, Kuznetsova AA.
Vestn Oftalmol. 2024;140(2):91-96. doi: 10.17116/oftalma202414002191.
Wolfram Syndrome 1: From Genetics to Therapy.
Rigoli L, Caruso V, Salzano G, Lombardo F.
Int J Environ Res Public Health. 2022 Mar 9;19(6):3225. doi: 10.3390/ijerph19063225.
